ORMP logo

Oramed Pharmaceuticals Inc.

ORMP

ORMP: Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

more

Show ORMP Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recently reported changes by institutional investors

Quarterly net insider trading by ORMP's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of ORMP in WallStreetBets Daily Discussion

ORMP News

Recent insights relating to ORMP

CNBC Recommendations

Recent picks made for ORMP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ORMP

Corporate Flights

Flights by private jets registered to ORMP